# Heparin for RAO Post-Transradial Angiography in AIS

Study · id `cardio:ct-nct07162064` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07162064](<https://clinicaltrials.gov/study/NCT07162064>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07162064

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.

## Technical summary

Registry record NCT07162064. Randomized; double masking; primary purpose prevention. Start 2025-08-04 (actual); primary completion 2026-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 440 participants (enrolled count; ClinicalTrials.gov record NCT07162064, source copy `cardio:ctgov-nct07162064-2026-03-24`, retrieved 2026-10-26)
- Started: 2025-08-04 (actual) (ClinicalTrials.gov record NCT07162064, source copy `cardio:ctgov-nct07162064-2026-03-24`, retrieved 2026-10-26)
- Primary completion: 2026-01-31 (actual) (ClinicalTrials.gov record NCT07162064, source copy `cardio:ctgov-nct07162064-2026-03-24`, retrieved 2026-10-26)
- Completion: 2026-02-04 (actual) (ClinicalTrials.gov record NCT07162064, source copy `cardio:ctgov-nct07162064-2026-03-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07162064, source copy `cardio:ctgov-nct07162064-2026-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07162064-2026-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Heparin for RAO Post-Transradial Angiography in AIS
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Heparin - Therapeutic dosage
- Intervention (Drug): Saline (0.9% NaCl)
- Lead sponsor: Xiang Luo
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xiang Luo (`cardio:org-xiang-luo`)

## Provenance

Content hash: d27845c32c605bc70984334d1b96f03295d88c926fe02ca586237b6936cbb075
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
